CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting. (Q42136462)
Jump to navigation
Jump to search
scientific article published on 6 January 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting. |
scientific article published on 6 January 2010 |
Statements
CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting (English)
James McCracken
Telma Martins da Palma
Aaron Lesher
Yueying Liu
Jeffrey J Roszkowski
Anquanette Temple
Glenda G Callender
Timothy Clay
Rimas Orentas
José Guevara-Patiño
Michael I Nishimura
1 reference
1 reference
1 reference
1 reference
1 reference